Sign In
Buy GTHX
$7.15
+0 (+0%)
At Close: Dec 16, 2024
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
03:01pm, Thursday, 05'th Jan 2023 Benzinga
Upgrades
For Algonquin Power & Utilities Corp (NYSE:AQN), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Algonquin Power showed an EPS of $0.11, compared
G1 Therapeutics Provides Initial Update on Phase 2 Bladder Cancer Trial; Progression Free Survival (PFS) Data Expected in Mid-2023
11:30am, Wednesday, 04'th Jan 2023 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today provided an initial update on PRESERVE 3, an ongoin
G1 Therapeutics to Participate in the 41st Annual J.P. Morgan Conference
07:00pm, Tuesday, 03'rd Jan 2023 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that on January 11, 2023, at 1:30 PM PST, G
Initial Results from Phase 2 Mechanism of Action Trial in Early-Stage Triple Negative Breast Cancer Show that a Single Dose of Trilaciclib Favorably Alters the Tumor Microenvironment
11:04pm, Wednesday, 07'th Dec 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today provided initial results from a 24 patient Phase 2
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:41am, Friday, 02'nd Dec 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 01, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exerc
G1 Therapeutics to Participate in the Virtual Evercore ISI HealthCONx Conference
03:30pm, Wednesday, 23'rd Nov 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 23, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that Jack Bailey, G1’s Chief Executive Of
G1 Therapeutics Announces Closing of Offering of Common Stock
09:01pm, Tuesday, 22'nd Nov 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 22, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the closing of an underwritten public offer
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
10:58am, Monday, 21'st Nov 2022 Benzinga
Gainers
AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday.
FOXO Technologies Inc. (NYSE: FOXO) shares surged 46.9% to close at $0.6520 on Friday. Foxo Technologies re
Nasdaq Down 0.5%; Clearfield Shares Spike Higher
07:46pm, Friday, 18'th Nov 2022 Benzinga
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping over 50 points on Friday.
The Dow traded up 0.19% to 33,608.80 while the NASDAQ fell 0.50% to 11,089.07. The S&P
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
06:15pm, Friday, 18'th Nov 2022 Benzinga
Gainers
PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.
Satixfy Communications Ltd. (N
Nasdaq Turns Lower; Crude Oil Down Over 3%
05:00pm, Friday, 18'th Nov 2022 Benzinga
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Friday.
The Dow traded up 0.42% to 33,686.06 while the NASDAQ fell 0.25% to 11,117.35. The S&P 500 also rose
Delta Apparel, Farfetch, American Software And Some Other Big Stocks Moving Lower On Friday
04:01pm, Friday, 18'th Nov 2022 Benzinga
U.S. stocks traded mixed, with the Dow Jones gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.
G1 Therapeutics, Inc. (NASDAQ: GTHX) dipped 24% to $
Why Farfetch Shares Are Trading Lower; Here Are 26 Stocks Moving Premarket
12:43pm, Friday, 18'th Nov 2022 Benzinga
Gainers
PaxMedica, Inc. (NASDAQ: PXMD) shares rose 58.1% to $2.45 in pre-market trading. PaxMedica entered into committed equity investment agreement for up to $20 million with Lincoln Park Capital.
G1 Therapeutics Announces Pricing of Offering of Common Stock
01:12am, Friday, 18'th Nov 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the pricing of an underwritten public offer
G1 Therapeutics Announces Proposed Public Offering of Common Stock
09:01pm, Thursday, 17'th Nov 2022 GlobeNewswire Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that it has commenced an underwritten publi
